Oxford spinout trials revolutionary bioelectronic implant to treat incontinence
1 February 2023
Clinical Trials General Innovation Research
The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.
COVID-19 is a leading cause of death in children and young people in the US
31 January 2023
Coronavirus COVID-19 General Research
A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.
Three or more concussions linked with worse brain function in later life
31 January 2023
Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.
New blood test could save lives of heart attack victims
31 January 2023
Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.
COVID-19 increased public trust in science, new survey shows
26 January 2023
Coronavirus COVID-19 General Research
A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.
Gero Miesenböck awarded 2023 Japan Prize
24 January 2023
Awards and Appointments General
Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.
Major funding for Oxford will help find new cancer treatments
23 January 2023
Awards and Appointments General Research
Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.
Daniel Freeman to join Department of Experimental Psychology as Professor of Psychology
23 January 2023
Awards and Appointments General
The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.
New study reveals role of lymphatic system in bone healing
19 January 2023
It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.
Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant
17 January 2023
Coronavirus COVID-19 General Research
The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.
Oxford to lead international consortium to unlock potential of programmable nucleic acid drugs
17 January 2023
Awards and Appointments General
A consortium led by Matthew Wood, Professor of Neuroscience in the Department of Paediatrics and Director of the Oxford-Harrington Rare Disease Centre, has been awarded £8m of funding from UKRI, LifeArc and the Nucleic Acid Therapy Accelerator (NATA) via the Nucleic Acid Therapies (NAT) Delivery Research Challenge.
Significant scale-up investment for three Oxford spinouts
16 January 2023
Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.
Molnupiravir doesn't reduce COVID-19 hospitalisations in high-risk vaccinated people
3 January 2023
Clinical Trials General Research
Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with COVID-19 in the community.
Professor Marian Knight recognised for services to maternal and public health
31 December 2022
Awards and Appointments General
Professor Knight's research focuses on the care and prevention of severe complications of pregnancy and early life and addressing disparities in outcomes for women and babies from different population groups.
Oxford vaccinologist Teresa Lambe honoured with Irish Abroad award
20 December 2022
Awards and Appointments General
A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.
Making smiles
19 December 2022
Photographer in Residence at Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, Pearl Gan's photograph is featured as one of the winners in The Lancet's Highlights 2022. Highlights is The Lancet's annual photography competition and this year's competition focussed on health-related topics.
Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
16 December 2022
New research from the MRC Weatherall Institute of Molecular Medicine has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
Oxford Ebola vaccine manufactured and shipped in record time by SII
16 December 2022
More than 40,000 doses of Oxford’s Ebola vaccine have been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.
‘Thinking Family’ when an adult has a serious illness
15 December 2022
Every day, thousands of parents and grandparents are diagnosed with serious health conditions such as cancer, lung or heart disease. They are then faced with the unenviable task of sharing this information with the children they love.
Director of MRC Brain Network Dynamics Unit appointed
15 December 2022
Awards and Appointments General
From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.